Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
<p>Abstract</p> <p>Background</p> <p>Thromboxane synthase (TXS) metabolises prostaglandin H2 into thromboxanes, which are biologically active on cancer cells. TXS over-expression has been reported in a range of cancers, and associated with a poor prognosis. TXS inhibiti...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-03-01
|
| Series: | Molecular Cancer |
| Online Access: | http://www.molecular-cancer.com/content/10/1/25 |